Estrogen Receptor Negative

Showing 1 - 25 of 43

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Edema, Erythema, Estrogen Receptor Negative Trial in Houston (Laboratory Biomarker Analysis, Pembrolizumab)

Active, not recruiting
  • Edema
  • +8 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 23, 2023

Estrogen Receptor Negative, HER2/Neu Negative, Invasive Breast Carcinoma Trial in South Africa, United States (drug, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +11 more
  • Mobile, Alabama
  • +1023 more
Dec 7, 2022

Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8

Active, not recruiting
  • Anatomic Stage IIB Breast Cancer AJCC v8
  • +19 more
  • Gilbert, Arizona
  • +4 more
Dec 6, 2022

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +15 more
  • Bellevue, Nebraska
  • +3 more
Nov 30, 2022

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

Suspended
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +18 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2022

Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)

Active, not recruiting
  • Triple -Negative Breast Cancer
  • +4 more
  • Biopsy
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 1, 2022

BARD1 Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston, Seattle (Educational Intervention, Genetic

Recruiting
  • BARD1 Gene Mutation
  • +14 more
  • Educational Intervention
  • +3 more
  • Houston, Texas
  • +1 more
Jun 14, 2022

Androgen Receptor Positive, Estrogen Receptor Negative, HER2/Neu Negative Trial in United States (drug, other, biological)

Active, not recruiting
  • Androgen Receptor Positive
  • +5 more
  • Corona, California
  • +6 more
Jun 8, 2022

Breast Adenocarcinoma, Estrogen Receptor Negative, HER2/Neu Negative Trial in Canada, United States (Carboplatin,

Recruiting
  • Breast Adenocarcinoma
  • +9 more
  • Mobile, Alabama
  • +1295 more
May 2, 2022

Adult Solid Tumor, Bladder Carcinoma, Colon Carcinoma Trial in Duarte (Laboratory Biomarker Analysis, Modified Vaccinia Virus

Active, not recruiting
  • Adult Solid Neoplasm
  • +16 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in United States (procedure, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +3 more
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
  • +3 more
  • Houston, Texas
  • +5 more
Feb 11, 2022

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Biomarker Analysis,

Active, not recruiting
  • Estrogen Receptor Negative
  • +6 more
  • Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +8 more
Feb 3, 2022

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage IA Breast Cancer AJCC v8
  • +27 more
  • Aspiration of Breast
  • Biospecimen Collection
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Oct 29, 2021

Collecting, Analyzing, and Storing Samples From Metastatic,

Terminated
  • Estrogen Receptor Negative
  • +4 more
  • Cytology Specimen Collection Procedure
  • +3 more
  • Seattle, Washington
  • +1 more
Sep 23, 2021

Estrogen Receptor Negative, HER2 Positive Breast Carcinoma, HER2/Neu Negative Trial in United States (External Beam Radiation

Recruiting
  • Estrogen Receptor Negative
  • +11 more
  • External Beam Radiation Therapy
  • +4 more
  • Phoenix, Arizona
  • +7 more
Aug 4, 2021

Inflammatory Breast Cancer, Stage IIA Breast Cancer, Stage IIIA Breast Cancer Trial in Duarte, South Pasadena (carboplatin,

Active, not recruiting
  • Inflammatory Breast Cancer
  • +9 more
  • Duarte, California
  • +1 more
Jul 9, 2021

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Completed
  • Anatomic Stage II Breast Cancer AJCC v8
  • +20 more
  • Mirvetuximab Soravtansine
  • Houston, Texas
    M D Anderson Cancer Center
Nov 18, 2020

Advanced Malignant Solid Tumor, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in

Completed
  • Advanced Malignant Solid Neoplasm
  • +24 more
  • Oxidative Phosphorylation Inhibitor IACS-010759
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 23, 2020

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Negative, HER2/Neu Negative Trial in Portland (Durvalumab, Olaparib)

Completed
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Nov 18, 2020

Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in Chicago, Lake Forest (drug, other,

Unknown status
  • Estrogen Receptor Negative
  • +9 more
  • Chicago, Illinois
  • +1 more
Jun 25, 2020

Breast Carcinoma Metastatic in the Brain, Estrogen Receptor Negative, HER2/Neu Negative Trial in Chicago, Lake Forest, Houston

Terminated
  • Breast Carcinoma Metastatic in the Brain
  • +6 more
  • Cognitive Assessment
  • +3 more
  • Chicago, Illinois
  • +2 more
Apr 2, 2020

Ductal Breast Carcinoma, Ductal Breast Carcinoma In Situ, Estrogen Receptor Negative Trial in Buffalo (Broccoli Sprout Extract,

Completed
  • Ductal Breast Carcinoma
  • +10 more
  • Broccoli Sprout Extract
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 29, 2019

Estrogen Receptor Negative, HER2/Neu Negative, Invasive Breast Carcinoma Trial in United States (Akt Inhibitor GSK2141795,

Completed
  • Estrogen Receptor Negative
  • +6 more
  • Akt Inhibitor GSK2141795
  • +2 more
  • Washington, District of Columbia
  • +7 more
Aug 27, 2019